In silico investigation of the effect of particle diameter on deposition uniformity in pulmonary drug delivery
暂无分享,去创建一个
[1] G. Scheuch,et al. Regional Lung Deposition: In Vivo Data. , 2020, Journal of aerosol medicine and pulmonary drug delivery.
[2] J. Khinast,et al. Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] Qihong Deng,et al. Particle Deposition in Human Lung Airways: Effects of Airflow, Particle Size, and Mechanisms , 2020 .
[4] M. Sakagami. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs. , 2020, Advanced drug delivery reviews.
[5] C. Darquenne. Deposition Mechanisms. , 2020, Journal of Aerosol Medicine.
[6] E. Matida,et al. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity. , 2019, Journal of aerosol medicine and pulmonary drug delivery.
[7] Runyu Yang,et al. CFD modelling of air and particle flows in different airway models , 2019, Journal of Aerosol Science.
[8] Yatin R. Gokarn,et al. Non-invasive delivery strategies for biologics , 2018, Nature Reviews Drug Discovery.
[9] S. Newman. Drug delivery to the lungs: challenges and opportunities. , 2017, Therapeutic delivery.
[10] Clement Kleinstreuer,et al. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application , 2017, Comput. Biol. Medicine.
[11] Georges Caillibotte,et al. The Creation and Statistical Evaluation of a Deterministic Model of the Human Bronchial Tree from HRCT Images , 2016, PloS one.
[12] A. Melikov,et al. Particle deposition in a realistic geometry of the human conducting airways: Effects of inlet velocity profile, inhalation flowrate and electrostatic charge. , 2016, Journal of biomechanics.
[13] Andrew R. Martin,et al. Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung. , 2016, Journal of aerosol medicine and pulmonary drug delivery.
[14] C. Kloft,et al. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs , 2015, The AAPS Journal.
[15] Lawrence X. Yu,et al. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences , 2015, The AAPS Journal.
[16] D. Klonoff. Afrezza Inhaled Insulin , 2014, Journal of diabetes science and technology.
[17] Joy Conway,et al. Airway Morphology From High Resolution Computed Tomography in Healthy Subjects and Patients With Moderate Persistent Asthma , 2013, Anatomical record.
[18] R. Narayanacharyulu,et al. In-Vitro, Ex-Vivo and In-Vivo Evaluation of Transdermal Delivery of Felodipine , 2013 .
[19] W. Finlay,et al. An In vitro Study on the Deposition of Micrometer-Sized Particles in the Extrathoracic Airways of Adults During Tidal Oral Breathing , 2013, Annals of Biomedical Engineering.
[20] H. Smyth,et al. Controlled Pulmonary Drug Delivery , 2011 .
[21] Jiyuan Tu,et al. Micron particle deposition in a tracheobronchial airway model under different breathing conditions. , 2010, Medical engineering & physics.
[22] G. Prisk,et al. Alveolar duct expansion greatly enhances aerosol deposition: a three-dimensional computational fluid dynamics study , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[23] Peter Brand,et al. Higher lung deposition with Respimat® Soft Mist™ Inhaler than HFA-MDI in COPD patients with poor technique , 2008, International journal of chronic obstructive pulmonary disease.
[24] R. Sturm,et al. Semi-Empirical Stochastic Model of Aerosol Bolus Dispersion in the Human Lung , 2008 .
[25] O. Usmani,et al. Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .
[26] Douglas R. Worsnop,et al. Particle Morphology and Density Characterization by Combined Mobility and Aerodynamic Diameter Measurements. Part 1: Theory , 2004 .
[27] Stephen P. Newman,et al. Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder , 2002, Pharmaceutical Research.
[28] W. Hofmann,et al. Particle Deposition in a Multiple-Path Model of the Human Lung , 2001 .
[29] R. Hermann,et al. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. , 2000, The European respiratory journal.
[30] J. Heyder,et al. Total deposition of therapeutic particles during spontaneous and controlled inhalations. , 2000, Journal of pharmaceutical sciences.
[31] J. Heyder,et al. Aerosol bolus dispersion in healthy subjects. , 1997, The European respiratory journal.
[32] D. Taylor,et al. Human Respiratory Tract Model for Radiological Protection , 1996 .
[33] B. Asgharian,et al. A multiple-path model of particle deposition in the rat lung. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[34] C. P. Yu. Exact analysis of aerosol deposition during steady breathing , 1978 .
[35] Otto G. Raabe,et al. Tracheobronchial Geometry: Human, Dog, Rat, Hamster - A Compilation of Selected Data from the Project Respiratory Tract Deposition Models , 1976 .
[36] D. Ingham. Diffusion of aerosols from a stream flowing through a cylindrical tube , 1975 .
[37] J. Beeckmans. THE DEPOSITION OF AEROSOLS IN THE RESPIRATORY TRACT. I. MATHEMATICAL ANALYSIS AND COMPARISON WITH EXPERIMENTAL DATA. , 1966, Canadian journal of physiology and pharmacology.
[38] Margaret J. Robertson,et al. Design and Analysis of Experiments , 2006, Handbook of statistics.
[39] H. Landahl. On the removal of air-borne droplets by the human respiratory tract: I. The lung , 1950 .
[40] Wenqi Zhong,et al. Numerical investigation of particle deposition in a triple bifurcation airway due to gravitational sedimentation and inertial impaction , 2018 .
[41] Yung-sung Cheng,et al. Deposition of Particles in Human Mouth-Throat Replicas and a USP Induction Port. , 2014, Journal of aerosol medicine and pulmonary drug delivery.
[42] Bo Olsson,et al. Pulmonary Drug Metabolism, Clearance, and Absorption , 2011 .
[43] Jinxiang Xi,et al. Computational investigation of particle inertia effects on submicron aerosol deposition in the respiratory tract , 2007 .
[44] Dale Farris,et al. Design of Experiments With MiNITAB , 2005 .
[45] J. Patton,et al. The lungs as a portal of entry for systemic drug delivery. , 2004, Proceedings of the American Thoracic Society.
[46] L. Borgström,et al. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. , 1994, The European respiratory journal.
[47] J. Heyder,et al. Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .
[48] A. Black,et al. Regional deposition of 2.5-7.5 μm diameter inhaled particles in healthy male non-smokers , 1978 .